Correlation of In-Hospital Antihypertensive Therapy with Clinical Outcomes in Hypertensive Patients Admitted with COVID-19: A Retrospective Single-Centre Study in South Africa

Background and study aim: Hypertension has been associated with severe COVID-19 manifestations and increased mortality rates, particularly in low- and middle-income countries. This study aimed to elucidate the impact of inpatient antihypertensive therapy on COVID-19 outcomes among hypertensive patients in a predominantly black population in South Africa, focusing on the role of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs).Patients and Methods: A retrospective analysis was conducted at King Edward VIII Hospital, South Africa, encompassing hypertensive patients hospitalised with laboratory-confirmed SARS-CoV-2 infection from June 2020 to December 2021. Data on demographics, comorbidities, antihypertensive therapy, clinical signs, laboratory markers, and outcomes were analysed. Statistical methods included univariate and multivariate logistic regression to identify predictors of mortality.Results: The study included 205 hypertensive patients with COVID-19, of whom 115 received ACEI/ARB therapy. Patients on ACEI/ARBs exhibited significantly lower requirements for oxygen therapy, steroid therapy, and mechanical ventilation. Notably, ACEI/ARB therapy was associated with a significant reduction in mortality (aOR=0.144, p<0.001), higher median oxygen saturation (p=0.002), and lower inflammatory markers on presentation (p<0.05). Conversely, initial findings suggested an increased mortality risk with calcium channel blocker use (OR=2.783, p=0.001), which did not remain significant after adjusting for confounders (aOR=1.388, p=0.544).Conclusion: ACEI/ARB use was associated with improved outcomes in hypertensive patients hospitalised with COVID-19 in a predominantly black population in South Africa. These findings support the continuation of ACEI/ARB therapy in hypertensive patients with COVID-19. Further research is warranted to explore the mechanisms underlying these associations and to validate these findings in larger, prospective studies.

Authors

Institutions

Publication Details

Journal
Afro-Egyptian Journal of Infectious and Endemic Diseases
Published
2025-09-15
DOI
https://doi.org/10.21608/aeji.2025.336759.1430
Primary Topic
COVID-19 Clinical Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Correlation of In-Hospital Antihypertensive Therapy with Clinical Outcomes in Hypertensive Patients Admitted with COVID-19: A Retrospective Single-Centre Study in South Africa

S Pillay, Ahmed Sameer Ikram
Afro-Egyptian Journal of Infectious and Endemic Diseases
COVID-19 Clinical Research Studies
article

Correlation of In-Hospital Antihypertensive Therapy with Clinical Outcomes in Hypertensive Patients Admitted with COVID-19: A Retrospective Single-Centre Study in South Africa

S Pillay, Ahmed Sameer Ikram
article en

Abstract

Background and study aim: Hypertension has been associated with severe COVID-19 manifestations and increased mortality rates, particularly in low- and middle-income countries. This study aimed to elucidate the impact of inpatient antihypertensive therapy on COVID-19 outcomes among hypertensive patients in a predominantly black population in South Africa, focusing on the role of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs).Patients and Methods: A retrospective analysis was conducted at King Edward VIII Hospital, South Africa, encompassing hypertensive patients hospitalised with laboratory-confirmed SARS-CoV-2 infection from June 2020 to December 2021. Data on demographics, comorbidities, antihypertensive therapy, clinical signs, laboratory markers, and outcomes were analysed. Statistical methods included univariate and multivariate logistic regression to identify predictors of mortality.Results: The study included 205 hypertensive patients with COVID-19, of whom 115 received ACEI/ARB therapy. Patients on ACEI/ARBs exhibited significantly lower requirements for oxygen therapy, steroid therapy, and mechanical ventilation. Notably, ACEI/ARB therapy was associated with a significant reduction in mortality (aOR=0.144, p<0.001), higher median oxygen saturation (p=0.002), and lower inflammatory markers on presentation (p<0.05). Conversely, initial findings suggested an increased mortality risk with calcium channel blocker use (OR=2.783, p=0.001), which did not remain significant after adjusting for confounders (aOR=1.388, p=0.544).Conclusion: ACEI/ARB use was associated with improved outcomes in hypertensive patients hospitalised with COVID-19 in a predominantly black population in South Africa. These findings support the continuation of ACEI/ARB therapy in hypertensive patients with COVID-19. Further research is warranted to explore the mechanisms underlying these associations and to validate these findings in larger, prospective studies.

Afro-Egyptian Journal of Infectious and Endemic DiseasesVol. 0(0)
University of KwaZulu-Natal (ZA)
Openalex Percentile: Top 70%
COVID-19 Clinical Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.